Many Patients With Advanced NSCLC Do Not Survive Beyond First-Line Therapy
Many patients with advanced non-small cell lung cancer (NSCLC) do not survive long enough to receive second-line therapy, according to...
Many patients with advanced non-small cell lung cancer (NSCLC) do not survive long enough to receive second-line therapy, according to...
Advanced disease at diagnosis is more likely among younger patients with non-small cell lung cancer (NSCLC), according to data presented...